AKKARAJU SRINIVAS purchased 12.3% of their position (244.30K shares) of KALARIS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.18M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/22/2026ACC: 0001231919-26-000532
Director10% Owner
Since Dec 2025
+196.80K
Net shares
Net buyer
$1.18M
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
263.71K acquired · 66.91K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+244.30K
Price / share
$4.83
Trade value
$1.18M
% of position
12.3%
5/20/2026
1.98M→2.22M
Common Stock
Indirect
Shares
−66.91K
Price / share
—
Trade value
—
% of position
0.6%
5/20/2026
10.72M→10.66M
Common Stock
Indirect
Shares
+14.94K
Price / share
—
Trade value
—
% of position
New position
5/20/2026
0.00→14.94K
Common Stock
Indirect
Shares
+4.47K
Price / share
—
Trade value
—
% of position
29.9%
5/20/2026
14.94K→19.41K
Total
Net shares
+196.80K
Net value
$1.18M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/20/2026 | P · Purchase | +244.30K | $4.83 | $1.18M | 12.3% | 1.98M | 2.22M |
| Common Stock Indirect | 5/20/2026 | J · J | −66.91K | — | — | 0.6% | 10.72M | 10.66M |
| Common Stock Indirect | 5/20/2026 | J · J | +14.94K | — | — | New position | 0.00 | 14.94K |
| Common Stock Indirect | 5/20/2026 | J · J | +4.47K | — | — | 29.9% | 14.94K | 19.41K |
| Total | +196.80K | $1.18M | ||||||
Derivative Transactions0
No derivative transactions reported